Cytophage Technologies Ltd.
CYTO.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -85.45% | -66.11% | -87.70% | 3,102.70% | -- |
| Total Receivables | -71.73% | -75.27% | -76.47% | -45.57% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 0.00% | 54.17% | -25.47% | 290.20% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 8.19% | -33.79% | -70.43% | -97.96% | -- |
| Total Current Assets | -80.45% | -65.84% | -86.14% | -43.29% | -- |
|
|
|||||
| Total Current Assets | -80.45% | -65.84% | -86.14% | -43.29% | -- |
| Net Property, Plant & Equipment | -22.93% | -14.19% | 7.97% | 14.75% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -49.74% | -43.69% | -59.27% | -16.74% | -- |
|
|
|||||
| Total Accounts Payable | 97.21% | 32.34% | 10.26% | -46.99% | -- |
| Total Accrued Expenses | 20.74% | 28.65% | -23.80% | -41.81% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -21.73% | -21.96% | -35.10% | -43.34% | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 25.56% | 8.62% | -17.39% | -82.78% | -- |
|
|
|||||
| Total Current Liabilities | 25.56% | 8.62% | -17.39% | -82.78% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -14.22% | -9.93% | -14.28% | -14.82% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -0.56% | -3.51% | -15.46% | -63.67% | -- |
|
|
|||||
| Common Stock & APIC | 0.53% | 4.45% | -5.34% | 43.43% | -- |
| Retained Earnings | -12.75% | -17.60% | -11.74% | -27.71% | -- |
| Treasury Stock & Other | 2.18% | 1.91% | -15.88% | 17.69% | -- |
| Total Common Equity | -72.89% | -59.34% | -74.35% | 621.64% | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -72.89% | -59.34% | -74.35% | 621.64% | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -72.89% | -59.34% | -74.35% | 621.64% | -- |
|
|
|||||